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Research Round Up- Prescribing Issues in the COVID-19 Pandemic 
Introduction 
The last research round up provided you with an overview of recent research around the theme of 
prescribing and care management during the COVID-19 global pandemic with a focus of prescribing 
for diabetes. This month we are going to review some disparate prescribing issues that have arisen 
and been reviewed due to the current pandemic. They are not directly connected to a specific 
theme, but all relevant to you as prescribers and there should be something there for everyone. 
 
Trends in Antibiotic Prescribing in Out-of-Hours Primary Care in England from January 2016 to June 
2020 to Understand Behaviours during the First Wave of COVID-19 
As we know as prescribers, antibiotic stewardship and appropriate prescribing of antibiotic therapy 
to reduce this incidence of resistance is an often-focussed field of research. In this open access 
article in the Journal- Antibiotics, the authors look at trends in the prescription of community 
antibiotics before and during the first wave of the COVID-19 pandemic and focus their review on 
data available in England. They accessed the records kept at practice level on the following aspects 
of prescribing; 
• Trends in total prescribing volume using a time series analysis 
• Prescribing of broad-spectrum antibiotics 
They were able to access records from January 2016-June 2020. They looked at antibiotic prescribing 
in the in-hours and out of hours setting for each year to establish the percentages prescribed in each 
arena and to review any trends or changes over time. The data showed an overall decline in 
antibiotic prescribing volume in primary care between 2016 and 2020. Although there appears to be 
a slight reduction in percentage prescribing overall, the level of out of hours prescribing per 1000 
inhabitants per day remains static. With regard to the prescribing of broad-spectrum antibiotics, the 
authors found that this, along with overall volume of prescribing decreased in the in-hours GP arena 
but the percentage of the use of broad spectrum as a factor of overall prescribing load was higher in 
out of hours care (OOH: 10.1%, IH: 8.7%). In OOH, co-amoxiclav and doxycycline peaked in March to 
May in 2020, which was out of sync with seasonality peaks (Winter) in previous years. While this 
increase might be explained by the implementation of the national guideline to use co-amoxiclav 
and doxycycline to manage pneumonia in the community during COVID-19, further investigation is 
required to see whether the observed reduction in OOH antibiotic prescribing persists and how this 
reduction might influence antimicrobial resistance and patient outcomes. The authors suggest that 
monitoring OOH prescribing should receive the same level of scrutiny afforded to IH prescribing to 
inform antimicrobial stewardship programmes. This is more important since, the boundaries 
between IH and OOH may have different meanings for the healthcare user in the current and 





Investigating the challenges and opportunities for medicines management in an NHS field hospital 
during the COVID-19 pandemic 
Medicines management is a huge part of prescribers, suppliers and administrator’s role in the NHS. 
The implementation of field hospitals in the COVID-19 pandemic brought up some unique challenges 
to medicines management in these novel settings. In this piece of original research published in the 
European Journal of Hospital Pharmacy the authors were instrumental in developing a framework 
set up a field hospital and ensure a standardisation of medicines management processes that were 
appropriate for operational implementation in the COVID-19 pandemic. They continuously evaluated 
their processes throughout the 7-week implementation period. The field hospitals (many known as 
Nightingale hospitals) were set up in a short space of time as a response to perceived increased 
volume of beds needed during the pandemic. The authors were mindful that this rapid set up 
presented challenges and opportunities for optimal medicines management. They sought to 
evaluate the process with a view to developing a framework to support future deployment of NHS 
field hospitals in response to medical needs. By using the PESTLE model 
(https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/fil







Some of the fundamental aspects for their consideration were political and legal as the medicines 
management framework had to be compliant with UK legislation. Environmental aspects such as 
storage and access were other important considerations. The framework helped identify other 
internal influencing factors that contributed to the complexity of managing medicines in this arena. 
These included workforce, governance and policy, and clinical factors such as prescribing, dispensing 
and administration.  
The technological processes the authors had available included an electronic prescribing system but 
the workforce who were to be deployed were unfamiliar and training was considered to much of a 
burden so a paper-based system was employed. The authors acknowledged the risk of this having 
less clinical support for decision making. The article also discusses important logistical aspects as 
well as issues around controlled drugs, medical gases and formularies.  
The authors conclude and recommend a broad team-working approach to any large-scale project 
such as the field hospital set up, and suggest the identified influencing factors be used as a core 
framework for development of any future MM processes in NHS field hospitals. They also 






Drug Shortages Amid the COVID-19 Pandemic 
Many of us will have heard media stories about drug shortage in the global pandemic, and some of 
you may have experienced drug shortages in your clinical area of practice. In this article published in 
US Pharmacist Journal the authors investigate the phenomenon of drug shortages and the role of 
the pharmacist in managing this from a USA perspective. They acknowledge that in some form or 
another drug shortages have been problematic for decades but the onset of the COVID-19 pandemic 
created an unprecedented demand for some drugs and an enhanced concern about drug availability. 
They point out that shortages are not only created by increased demand for certain drugs (the most 
media notable being hydroxychloroquine) but the significant impact that the pandemic put on 
production and supply of many drugs. As discussed in the piece, this came down to reduced supply 
of raw materials, especially those required to be imported form COVID-19 affected countries. This 
reduction in raw materials impacts on the ability of drug production companies’ ability to maintain 
production levels. This could then be further complicated by disruption to the ongoing supply chain.  
The example of hydroxychloroquine shows how media attention and purported use in the treatment 
of COVID impacted prescribing practice for a drug normally prescribed in relatively small quantities 
due to the nature of the conditions it is used for. The article cites figures from 2020, post the 
Emergency Use Authorisation in March of that year for COVID treatment. In February of that year 
383,435 prescriptions were issued. This increased to 759,186 the following month, creating 
immediate shortages in local supplies. This prompted state pharmacy boards to implement new 
rules to control use to protect supplies as far as possible. This in conjunction with treatment 
guidelines regarding the drugs use in COVID led to the return to pre pandemic prescribing trends.  
In the face of these drug shortages, pharmacy personnel responded by initiating local policy changes 
and enacting quantity limits for in-demand medications. Pharmacists play a vital role in a drug 
shortage because of their unique skills and ability to bridge shortage gaps with effective action plans 
to maintain patient safety. 
https://www.uspharmacist.com/article/drug-shortages-amid-the-covid19-pandemic 
Conclusion 
It is clear that the COVID-19 pandemic continues to impact on many aspects of healthcare provision 
and this month’s focus on some prescribing related publications suggests that this disease burden on 
our health services extends far beyond the diagnosis, treatment and management of COVID-19 
itself. It is likely that this will continue for some time and we can expect many COVID related 
publications to emerge, new impacts that have been elucidated as well as longer term studies 
showing effects over time. Never has it been more important to maintain our continued professional 
development and read evidence around prescribing and our areas of clinical practice.  
